Bio-IT World Podcast: Don’t Risk Losing “Ownership” of Your Research IP

April 12, 2011 - PRLog -- Needham, MA – Bio-IT World announces the podcast series entitled Don’t Risk Losing “Ownership” of Your Research IP in Your Electronic R&D Environment.  

Sponsored by Surety, this podcast series will focus on laboratories and R&D-dependent bio-pharma and life sciences organizations, and as they move to electronic workflows in their lab environments, the need to protect Scientific Intellectual Property (trade secrets, formulas, ideas and collaboration) is paramount. But if you aren’t protecting the integrity of your research data in your lab management workflows, you risk losing ownership, revenue and potentially your business if you can't prove time of creation (“first-to-invent”) and authenticity. Surety hosted a podcast series with Michael Elliot of Atrium Research & Consulting and Timothy Carroll, Partner at Loeb & Loeb, LLP, discussing important topics that can improve your organization's IP data security and integrity.

The podcast series includes discussions on:

-  The benefits of an electronic R&D environment

-  Across-the-board, data-level security controls that must be in place to protect Scientific  Intellectual Property (IP) as the” lifeblood” of the organization

-  How digital timestamp technology can act as “trusted witness” to protect the integrity and legally defend the authenticity and ownership of IP.

In part 1 of this podcast series, the Benefits of an Electronic Lab Environment, Elliot and Carroll discuss how companies going the way of eR&D are improving laboratory efficiencies, from the conception of experiments through information delivery.

Part 2 of this podcast series, entitled Data-level Security and Authenticity Controls: a Trusted Witness in Electronic R&D Environments. This podcast will discuss how during the past few years many companies tried extending their traditional records policies to the way in which they managed e-mail and electronic records, hoping for a one-size-fits-all approach. But is this inviting risk? Listen in, as Elliot and Carroll mull over the types of controls an organization can put in place to ensure data integrity for electronic documents.

To access this complimentary podcast series, visit:  http://www.bio-itworld.com/BioIT_Podcasts.aspx

Companies interested in sponsoring a white paper, should contact John Kistner at 781.972.1354 or  jkistner@healthech.com.  A variety of custom publishing and multi-media solutions are available to convey your company’s message to a core clinical research audience of qualified scientists, researchers, technology professionals, executive managers, clinical professionals in pharma, biotech, academia, and niche service provider companies on eCliniqua.com or Bio-ITWorld.com.  Recent white paper sponsors have included HP, Pegasystems, Cmed Technology, BlueArc and Quantum.

About Bio-IT World:  (http://www.bio-itworld.com)
Part of the Cambridge Healthtech Institute Media Group (http://www.chimediagroup.com), Bio-IT World magazine is a bimonthly publication that life science and IT/informatics professionals continuously reference to find information, news, and commentary on indispensable technologies and business strategies.  Bio-IT World provides outstanding coverage of cutting-edge trends and technologies that impact the management and analysis of life sciences data, including next-generation sequencing, drug discovery, predictive and systems biology, informatics tools, clinical trials, and personalized medicine.

Cambridge Healthtech Media Group also hosts daily news and opinion at http://www.bio-itworld.com, a variety of e-newsletters, and a rich compendium of webinars and web symposia. Cambridge Healthtech Media Group is based in Needham, Mass.

Contact: Lisa Scimemi, Corporate Marketing Communications Director, Cambridge Healthtech Media Group, lscimemi@healthtech.com or 781.972.5446.

# # #

Bio-IT World focuses on the tools and results of predictive biology, drug discovery, informatics, clinical trials, and personalized medicine as well as the strategic decisions made by companies in this area and the impact on the company’s performance.